Level Four Advisory Services’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
JT
PA
NAMI
Level Four Advisory Services's TVTX Position: Q2 2026 in Review
Level Four Advisory Services opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 5,506 shares worth $313K. The stake represents 0.01% of the portfolio and ranks #755 among its holdings. This is a return to the name: Level Four Advisory Services previously reported a position in TVTX as recently as Q4 2025.
Level Four Advisory Services first reported a position in TVTX in Q4 2025 and has held it in 2 quarters since. 319 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Level Four Advisory Services held 5,506 shares of Travere Therapeutics worth $313K as of Q2 2026.
- Travere Therapeutics was a new Level Four Advisory Services position in Q2 2026.
- Travere Therapeutics made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #755 holding.
- Level Four Advisory Services first reported a position in Travere Therapeutics in Q4 2025 and has held it in 2 quarters since.
- 319 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.